Gsk (GSK) Assets Average (2009 - 2026)
Gsk (GSK) posted Assets Average of $314.1 billion for Q4 2025, down 8.08% on a QoQ basis from $341.7 billion in Q4 2024, and down 8.08% year-over-year from $341.7 billion in Q4 2024.
Gsk (GSK) has 6 years of Assets Average data on file, last reported at $314.1 billion in Q4 2025.
- In Q4 2025, Assets Average fell 8.08% year-over-year to $314.1 billion; the TTM figure through Dec 2025 stood at $314.1 billion (down 8.08% YoY), while the FY2025 annual figure was $78.8 billion, up 5.39% from the prior year.
- Assets Average eased to $314.1 billion in Q4 2025, from $341.7 billion in the prior quarter.
- Across five years, Assets Average topped out at $371.2 billion in Q4 2023 and bottomed at $314.1 billion in Q4 2025.
- A 4-year average of $344.4 billion and a median of $346.1 billion in 2022 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average grew 5.89% — and 2025, when it retreated 8.08%.
- Year by year, Assets Average stood at $350.6 billion in 2022, then grew by 5.89% to $371.2 billion in 2023, then slipped by 7.96% to $341.7 billion in 2024, then retreated by 8.08% to $314.1 billion in 2025.
- The last three Assets Average figures came in at $314.1 billion (Q4 2025), $341.7 billion (Q4 2024), and $371.2 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 114.53 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 200.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 135.21 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 132.78 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 91.55 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 57.65 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 208.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 88.26 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 314.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.03 Bn |
| Dec 31, 2025 | 82.03 Bn |
| Sep 30, 2025 | 80.91 Bn |
| Jun 30, 2025 | 77.76 Bn |
| Mar 31, 2025 | 76.39 Bn |
| Dec 31, 2024 | 75.87 Bn |
| Sep 30, 2024 | 74.36 Bn |
| Jun 30, 2024 | 73.76 Bn |
| Mar 31, 2024 | 73.73 Bn |
| Dec 31, 2023 | 75.16 Bn |
| Sep 30, 2023 | 75.75 Bn |
| Jun 30, 2023 | 72.82 Bn |
| Mar 31, 2023 | 70.89 Bn |
| Dec 31, 2022 | 70.81 Bn |
| Sep 30, 2022 | 91.61 Bn |
| Jun 30, 2022 | 86.27 Bn |
| Mar 31, 2022 | 83.52 Bn |
| Dec 31, 2021 | 107.56 Bn |
| Sep 30, 2021 | 108.06 Bn |
| Jun 30, 2021 | 107.65 Bn |
| Mar 31, 2021 | 106.93 Bn |
| Jun 30, 2020 | 106.63 Bn |
| Mar 31, 2020 | 105.31 Bn |
| Dec 31, 2019 | 102.56 Bn |
| Sep 30, 2019 | 92.26 Bn |
| Jun 30, 2019 | 81.52 Bn |
| Mar 31, 2019 | 77.95 Bn |
| Dec 31, 2018 | 75.55 Bn |
| Sep 30, 2018 | 77.45 Bn |
| Jun 30, 2018 | 78.32 Bn |
| Mar 31, 2018 | 76.49 Bn |
| Dec 31, 2017 | 75.89 Bn |
| Sep 30, 2017 | 75.67 Bn |
| Jun 30, 2017 | 73.89 Bn |
| Mar 31, 2017 | 73.41 Bn |
| Dec 31, 2016 | 75.37 Bn |
| Sep 30, 2016 | 80.02 Bn |
| Jun 30, 2016 | 80.42 Bn |
| Mar 31, 2016 | 79.59 Bn |
| Dec 31, 2015 | 82.64 Bn |
| Sep 30, 2015 | 83.79 Bn |
| Jun 30, 2015 | 85.69 Bn |
| Mar 31, 2015 | 76.18 Bn |
| Dec 31, 2014 | 65.89 Bn |
| Sep 30, 2014 | 66.37 Bn |
| Jun 30, 2014 | 65.54 Bn |
| Mar 31, 2014 | 66.92 Bn |
| Dec 31, 2013 | 65.93 Bn |
| Sep 30, 2013 | 64.16 Bn |
| Jun 30, 2013 | 65.64 Bn |
| Mar 31, 2013 | 35.22 Bn |
| Dec 31, 2012 | 33.83 Bn |
| Sep 30, 2012 | 65.57 Bn |
| Jun 30, 2012 | 65.68 Bn |
| Mar 31, 2012 | 33.95 Bn |
| Dec 31, 2011 | 35.24 Bn |
| Sep 30, 2011 | 67.65 Bn |
| Jun 30, 2011 | 68.40 Bn |
| Mar 31, 2011 | 67.45 Bn |
| Dec 31, 2010 | 66.42 Bn |
| Sep 30, 2010 | 65.19 Bn |
| Jun 30, 2010 | 66.90 Bn |
| Mar 31, 2010 | 69.78 Bn |
| Dec 31, 2009 | 69.01 Bn |
| Sep 30, 2009 | 61.85 Bn |
| Jun 30, 2009 | 55.98 Bn |
| Mar 31, 2009 | 59.13 Bn |